Disseminated paracoccidioidomycosis: Correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole

Mycoses

Volumn 46, Issue 8, 2003, Pages 342-347

  Hahn, Rosane Christine ^a   Morato Conceição, Yvelise Teresinha ^b   Santos, Niriana Lara ^a   Ferreira, Jussara Fialho ^b   Hamdan, Jünia Soares ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b HOSPITAL UNIVERSITÁRIO JÚLIO MÜLLER   (Brazil)

Author keywords

Antimycotic chemotherapy; Clinical resistance; Ketoconazole; Paracoccidioidomycosis; Sulphamethoxazole trimethoprim; Susceptibility

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; HUMAN; IN VITRO STUDY; INTESTINE INFECTION; MALE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PRIORITY JOURNAL; SOUTH AMERICAN BLASTOMYCOSIS;

ADULT; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, FUNGAL; HUMANS; KETOCONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

PARACOCCIDIOIDES BRASILIENSIS;

EID: 0141787101     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Brummer E, Castañeda E, Restrepo A. Paracoccidioi-domycosis: an update. Clin Microbol Rev 1993; 2: 89-117.
2. Franco M, Host-parasite relationships in paracoccidioidomycosis. J Med Vet Mycol 1986; 25: 5-18.
3. Restrepo MA. The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. Sabouraudia 1985; 23: 323-34.
4. Bethlem EP, Capone D, Maranhão B, Carvalho CRB, Wanke B. Paracoccidioidomycosis. Curr Opin Pulm Med 1999; 5: 319-25.
5. Shadomy S, Espine-Ingroff A, Cartwright RY. Estudios de laboratório com agents antifungicos: pruebas de susceptibilidade y bioensayos. In: Lenette EH. Balows A, Hausler WJ. Shadomy HJ (eds). Manual de Microbiologia Clínica, 4th edn. Buenos Aires: Editorial Medica, Panamericana, 1987; 1229-38.
6. Hahn RC, Hamdan JS. In vitro susceptibilities of Pararacoccidioides brasiliensis yeast form to antifungal drugs. Mycoses 2000; 41: 403-7.
7. Jessup CJ, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol 2000; 38: 155-9.
8. Mcginnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol 1998; 16: 243-6.
9. Hiratani T, Asagi Y, Yamaguchi H. Evaluation of in vitro antimycotic activity of terbinafine, a new allylamine agent. Jpn J Med Mycol 1991; 32: 323-32.
10. Gabellini GC, Martinez R, Ejima FH et al. Paracoccidioidomicose do estömago. Relato de caso e considerações sobre a patogenia desta lesão. Arq Gastroenterol 1992; 29: 147-52.
11. Mendes RP. The gamut of clinical manifestations. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G (eds). Paracoccidioidomycosis. Boca Raton, Florida: CRC Press, 1994; 233-58.
12. Meyer TN, Obstrução duodenal por Blastomicose Sul Americana. Rev Assoc Med Bras 1982; 28: 73-74.
13. Martinez R, Moderna JLP, Barbieri-Netto J, Fiorillo AM. Avaliação endoscopica do comprometimento de esôfago, estômago e duodeno na paracoccidioidomycosis humana. Arq Gastroenterol 1986; 21: 21-25.
14. Mendes RP, Negroni R, Arechavala A. Treatment and control of cure. In: Franco M, Lacaz DS, Restrepo-Moreno A, Del Negro G (eds), Paracoccidioidomycosis. Boca Raton: CRC Press. 1994: 373-92.
15. Rivitti EA, Aoki V. Deep fungal infections in tropical countries. Clin Dermatol 1999; 17: 171-90.
16. Prancesconi Do Valle AC, Wanke B, Wanke NCF, Peixoto TC, Perez M. Tratamento da Paracoccidioidomicose: estudo retrospectivo de 500 casos. An Bras Dermatol 1992; 67: 251-4.
17. Pedrosa PN, Wanke B, Coura JR. Emprego da associação sulfametoxazol-trimetoprim no tratamento da paracoccidioidomicose (blastomicose Sul Americana). Rev Soc Bras Med Trop 1974; 8: 159-65.
18. Restrepo AM, Arango MD. In vitro susceptibility testing of Paracoccidioides brasiliensis to sulfonamides. Antimicrob Agents Chemother 18: 190-4.
19. Marcondes J, Meira DA, Mendes RP et al. Avaliação do tratamento da paracoccidioidomicose com o cetoconazol. Rev Inst Med Trop São Paulo 1984; 26: 113-21.
20. Cucé LC, Belda WJ, Oliveira VM, Paracoccidioidomicose resistente ao cetoconazol - Relato de três casos. An Bras Dermatol 1987; 62: 203-4.
21. Cucé LC, Oliveira ZNP, Duarte AA. Paracoccidioidomicose resistente à anfotericina e cetoconazol - relato de um caso. Bol Cient SFMC 1984; 16: 57-59.
22. Rex JH, Pfaller MA, Lancaster M, Odds FC, Bolmstrom A, Rinaldi MG. Quality control guidelines for National Committee for Clinical Laboratory Standards - recommended broth macrodilution testing of ketoconazole and itraconazole. J Clin Microbiol 1996; 34: 816-7.
23. Restrepo A, Gomes I, Cano LE et al. Post-therapy status of paracoccidioidomycosis patients treated with ketoconazole. Am J Med 1985; 78: 53-57.
24. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
25. Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999; 141: 36-40.